> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Fresenius Kabi Recalls Infusion Pumps
- URL: https://www.fdaweb.com/fresenius-kabi-recalls-infusion-pumps/
- Published: 2019-08-12T12:00:00.000Z
- Updated: 2026-09-15T01:43:12.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5144746

Fresenius Kabi has recalled its Volumat MC Agilia Infusion Pumps and Vigilant Agilia Drug Library due to a “low priority — keep vein open, end of infusion” alarm and multiple software errors. “When enabled, the ‘keep vein open, end of infusion’ alarm triggers when the infusion is complete,” a [recall notice](https://www.fda.gov/medical-devices/medical-device-recalls/fresenius-kabi-recalls-volumat-mc-agilia-infusion-pump-and-vigilant-agilia-drug-library-due-low?ref=fdaweb.com) says. The alarm results in the therapeutic rate of a medication changing to a non-therapeutic rate, it says. Such alarms should be high priority, and if not treated in this manner could lead to an under-infusion of a critical medication.

Fresenius says it will change the alarm setting from a “low priority” to a “high priority” alarm to ensure that health care providers know the infusion has completed. It has also identified four software errors occurring with both the Volumat MC Agilia Infusion System and Vigilant Drug Library that may cause over-infusion or under-infusion of fluids/medications. These software errors could cause serious patient harm or death. There have been zero injuries and 14 complaints reported related to these software errors. The company says it will correct these on site.